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Cattle are an incredibly valuable asset to farmers throughout the world (Fig 1). They provide
power, transport, fertiliser, fuel, and nutrition. In some areas, cattle guarantee a family’s food
and economic security and act as important indicators of social status. In Africa, there are esti-
mated to be over 360 million cattle, an increase of 22% between 2010 and 2019 [1]. As the con-
tinent continues its population and economic growth, improved productivity and sustainable
growth of livestock will be required to meet the demand for food while mitigating their nega-
tive impacts.
Cattle are host to a plethora of infectious agents including viruses, bacteria, prions, and a
range of parasites comprising worms, ectoparasites, and protozoa. Many cattle pathogens are
closely related to pathogens of humans, including some that are zoonotic or with zoonotic
potential. Any infectious disease that causes loss of cattle life or decreased productivity (work,
growth, or fertility) imposes an economic impact. This burden heavily and disproportionately
affects low- and-middle-income countries and, in particular, smallholder farmers and pasto-
ralists. Among the myriad of infectious agents of cattle in sub-Saharan Africa, there are a small
selection of protozoan pathogens that collectively cost the region’s economy billions of US$
per annum. These are some of the biggest constraints to livestock production across sub-Saha-
ran Africa, affecting food security and hindering socioeconomic development.
Here, we examine the current situation and ongoing progress made in tackling these dis-
eases. Typically, human-infective parasites are subject to more experimental research than rel-
atives that infect cattle. We highlight the discrepancy in our knowledge and research capacity
between human and veterinary parasites. This research gap needs to be addressed if the effects
of such pathogens on livestock are to be more effectively prevented. We describe the improved
tools and resources needed so that these parasitic diseases can be studied effectively.
Which protozoan diseases impact cattle farming in sub-Saharan Africa?
The parasites that cause the most significant protozoan diseases in cattle in sub-Saharan Africa
belong to order Kinetoplastida (phylum Euglenozoa) and the phylum Apicomplexa, taxa
which encompass some of the world’s most devastating disease-causing parasitic species for
humans, livestock, and crops.
Kinetoplastid pathogens of cattle in sub-Saharan Africa. The African trypanosomes
Trypanosoma congolense, Trypanosoma vivax, and, to a lesser extent, Trypanosoma brucei are
the causative agents of bovine animal African trypanosomiasis (AAT) or nagana. These para-
sites are also able to infect a number of livestock, e.g., small ruminants and camels, and are
transmitted via a tsetse fly vector (Glossina spp.). Symptoms of acute bovine AAT include
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fever, anaemia, and weight loss and can be fatal. Most cases, however, develop into chronic dis-
ease associated with weakness, neurological symptoms, and reduction in milk production and
fertility. T. congolense and T. brucei are geographically restricted to the “tsetse belt” across sub-
Saharan Africa, although T. vivax has additionally established in South America through
mechanical transmission by stable flies (Stomoxys) and horse flies (Tabanids). Given the
worldwide distribution of these latter fly species, it is possible that that the geographical range
of T. vivax could expand. While T. brucei is the least pathogenic of the 3 bovine AAT-causing
species of African trypanosomes, 2 of the 3 subspecies of T. brucei are human infective, causing
human African trypanosomiasis (HAT). More distantly related human-infective kinetoplastids
include Trypanosoma cruzi, which causes Chagas disease in South America and over 20 Leish-
mania species that cause leishmaniasis.
Apicomplexan pathogens of cattle in sub-Saharan Africa. The Apicomplexa are a large
group of intracellular pathogens. In humans, diseases resulting from apicomplexan infection
include malaria, toxoplasmosis, and babesiosis. Across sub-Saharan Africa, the most important
Fig 1. Cattle in rural Kenya. Photograph from February 2020, taken by R. E. R. Nisbet.
https://doi.org/10.1371/journal.ppat.1009955.g001
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veterinary apicomplexans for cattle are 2 piroplasma species: Theileria parva, the causative
agent of the East Coast fever (ECF), and Babesia bovis and Babesia bigemina, causative agents
of bovine babesiosis (Table 1). Other apicomplexan species cause tropical theilerioses, crypto-
sporidiosis, toxoplasmosis, neosporosis, besnoitiosis, and eimeriosis in cattle.
T. parva is transmitted by ticks (Rhipicephalus appendiculatus), which feed on the blood of
cattle and other mammals. During tick feeding, T. parva sporozoites enter into the cattle
bloodstream. The extracellular sporozoites attach and enter host cells, primarily lymphocytes.
Table 1. Research methods used for the study of human disease–causing parasite species that could be applied to cattle disease–causing parasites [2–9]. Note that
the nonhuman infective subspecies of T. brucei (T. b. brucei) is the most widely used African trypanosome in the laboratory, acting as a model system for the human-infec-
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As these methods can be carried out without GM, it is somewhat straightforward to conduct genomics, bioinformatics,
transcriptomics and proteomics (whole cell or sub-cellular quantitative mass spectrometery) on any species where sufficient
interest, resources and starting material allows. Note that due to differential gene expression between parasite life-stages, often
studies are comparative.
Examples Genomes are available for T. congolense and
T. vivax, although are less heavily curated
than for T. brucei.
There are five whole-cell proteomics datasets
for BSF T. brucei available at TriTrypDB.org,
providing evidence of expression of over
5000 proteins in the BSF. Only one such
study is available for T. congolense, providing
evidence of expression of ~2000 proteins in
BSFs.
To date, there are no sub-cellular proteomics
studies on T. congolense. Methods developed
for T. brucei should be transferable, albiet
with optimisation.
Genomes and whole cell transcriptomes are available for T. parva, B. bovis and
B. bigemina.
Only T. parva has been subject to whole-cell quantitative proteomics, in the
sporozoite life-stage. Alongside standard whole-cell transcriptomics, there have
been a range of single-cell transcriptomic studies carried out in Plasmodium sp.
and Toxoplasma gondii.
There are a number of whole-cell and sub-cellular proteomics studies for
Plasmodium sp. and T. gondii. Recently, a whole-cell spatial proteome was







In vitro cell culture and GM is routine for T.
brucei BSFs, including RNAi. In vitro culture
of T. congolense BSFs is possible for one
isolate and there has been significant
developments in tools for growth and GM in
recent years, vastly improving experimental
tractability of this species. Equivalent
methods for T. vivax still lag behind.
In vitro cell culture established for T.
parva schizont stage. No genetic
modification is yet possible; establishing
a stable GM methodology is a priority.
In vitro culture of B. bovis is
established. Stable GM is possible,
including CRISPR/Cas9 genome
editing. No genome-wide studies have
been published.
Examples Genome wide RNAi and gain-of-function
studies have been conducted in T. brucei,
providing phenotypic data on over 7000
genes in each case.
A genome wide CRISPR screen has been carried conducted for T. gondii
providing phenotypic data (fitness score) for over 8000 genes.
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Once inside, the parasite rapidly dissolves the host-derived parasitophorous vacuole mem-
brane (PVM) and proliferates as an intracellular schizont in the host cell cytoplasm. The para-
site immortalises the infected host cells, resulting in a cancer-like uncontrolled proliferation
[10]; the molecular basis for this remains mostly uncharacterised. The cattle suffer diarrhoea,
fever, anorexia, and laboured breathing. In 1999, it was estimated that stock losses to ECF were
1 million cattle [11]. It is reasonable to assume that annual losses have increased with cattle
numbers. T. parva originated in the wild African buffalo (Syncerus caffer) population, where
the parasite is ubiquitous but does not typically cause disease.
Bovine babesiosis is most commonly found in tropical and subtropical countries, especially
in sub-Saharan Africa and South America. Two main species cause disease in African cattle, B.
bovis and B. bigemina, and are transmitted by Rhipicephalus ticks. Following tick bite, the para-
sites invade host red blood cells, causing anaemia and fever, and infection can also lead to cere-
bral babesiosis (B. bovis only) and death of cattle. A recent South African survey revealed that
up to three-quarters of cattle may be infected, dependent on region [12]. Although these cattle
may appear healthy, they can have decreased milk and meat production, as well as acting as
carriers for transmission [12].
What preventions and treatments are available against these protozoan
infections in cattle?
Efforts to control parasitic disease are hindered by the challenge of implementing vector con-
trol strategies across the vast expanses of tsetse and tick-populated land; emerging drug resis-
tance and the prevalence of counterfeit drugs; and a lack of suitable vaccination programmes.
Tick and tsetse fly control are used to prevent against infections, as has been the case for
many generations. Vector control is complex and comes with many limitations, including the
following: (i) Tsetse- and tick-infected regions are vast; therefore, traps can only provide a
local level of protection, which needs to be ongoing; (ii) ticks and related insects are a valuable
source of nutrition to reptiles and birds and so large-scale insecticide use is not feasible; (iii)
cattle plunge-dipping into toxic organophosphates or synthetic pyrethroids can cause signifi-
cant illness to the farmer and the environment and is not a widely available control option;
and (iv) the choice of insecticides used are key, due to selective toxicity and resistance [13].
Vaccination of cattle to prevent disease transmission is therefore considerably preferable to
arthropod management. Although ECF and babesiosis are both preventable diseases through
live cell vaccination, such vaccines require a cold chain from lab to cow, which is inappropriate
for use in rural settings due to expense and logistics. Additionally, vaccination with T. parva is
followed by antibiotic treatment in a simultaneous infection treatment immunisation model.
These impracticalities mean that the vaccine is not widely used. A modern subunit, RNA or
DNA vaccine, is urgently required [14].
No vaccine against AAT exists and has long been thought unlikely to be developed. This is
largely due to the parasites immune evasion strategy of antigenic variation as well as the appar-
ent lack of natural capacity for cattle to clear infection, despite the presence of antibodies to
nonvariant surface proteins. However, an AAT vaccine that could prevent establishment of the
infection would be hugely valuable, and recent work has identified a well-conserved T. vivax
vaccine target, against which vaccination in a murine model results in long-term sterile immu-
nity [15].
The primary drug available to treat ECF is buparvaquone; this is over 30 years old and
expensive to use, yet, to our knowledge, no new drugs are under development. Buparvaquone
is also used to control Theileria annulata (causative agent of tropical theileriosis), and resis-
tance due to mutations in the cytochrome b gene has been identified. The primary treatment
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for babesiosis is imidocarb. Concerns have been raised regarding use of imidocarb in livestock
due to its passage into milk and retention in tissues that are then used as human food [16].
Currently, AAT is primarily controlled by regular administration of prophylactic isometami-
dium chloride and therapeutic diminazene aceturate and homidium bromide/chloride. The
latter is a mutagenic (possibly carcinogenic) DNA intercalating agent, which can be toxic at
high doses. Benzoxaboroles have been identified as a potential new class of veterinary drugs
against AAT (for example, see [17]), with research and development underway.
Can the developments in research on human-infective protozoa inform our
understanding of cattle parasites?
Typically, human-infective parasites are subject to more experimental research than relatives
that infect cattle. This research gap needs to be addressed if the effects of such pathogens on
livestock are to be more effectively prevented. The cellular and infection biology of cattle-
infecting parasites do vary from human-infective species and so cannot always be reliably
inferred. For example, many apicomplexan parasites are motile and invade host cells using an
apical complex, forming a pointed end to the cell [18]. In contrast, Theileria parasites are non-
motile and do not reorient during host cell invasion. These differences are fundamental when
designing subunit vaccines against cell surface proteins. Similarly, while the mutations that
lead to diminazene aceturate resistance have been characterised in T. brucei, the mode of resis-
tance in T. congolense and T. vivax is both distinct and unknown [19,20]. However, many of
the tools and techniques developed for human-infective pathogens can be adapted for use in
animal pathogens.
Table 1 describes some of the important issues that require addressing. For African try-
panosomes, this includes the need to establish culturing techniques for T. vivax, improved cul-
ture systems for T. congolense (especially to permit growth of additional bloodstream form
strains) and established robust genetic modification protocols, progress for which has been
recently made [3]. For the apicomplexans, in vitro culture and stable genetic modification of
B. bovis are possible, but only one life stage of T. parva can be grown in vitro, with no ability to
genetically modify to date. For all of the species discussed here, whole-cell proteomics and
genome-wide knock-out studies, akin to those previously carried out in related human-infec-
tive species, would be extremely beneficial. A combination of improved experimental tractabil-
ity and large datasets would provide a step change in the capacity to study these veterinary
important organisms.
While conscious of biological differences, advances in human-infective parasitology
research can and should be exploited wherever possible to improve research capacity and
knowledge of cattle parasites. For example, related parasite species often have similar capacity
for genetic modification, so experimental protocols (i.e., transfection methodology) and
resources (i.e., plasmids) developed in one species can be the starting point for developing
methods for others. Similarly, the advancement of experimental techniques in one species (i.e.,
optimisation of cell fractionation methods for subcellular proteomics) may then facilitate the
use of that technique in related organisms. Where novel biology is uncovered, the assessment
of similar features (i.e., conserved protein function) in related species is less resource demand-
ing than the original discovery. Finally, the development of treatments or prevention measures
against human-infective species could have real impact on cattle diseases if they were studied
or developed in parallel.
There is no doubt that veterinary important species continue to be understudied compared
to their human-infective counterparts and that we cannot simply extrapolate data from one
species to another. However, this is progressively being recognised as an important area of
PLOS PATHOGENS
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009955 October 14, 2021 5 / 7
research and with the ability to draw on data and methodology from human-infective parasite
species, the scientific community is well placed to start to close this gap.
Acknowledgments
We thank Dr Naftaly Githaka (ILRI) for helpful discussion.
References
1. Nations FaAOotU. Available from: http://www.fao.org/faostat/en/#data/QCL.
2. Alsford S, Turner DJ, Obado SO, Sanchez-Flores A, Glover L, Berriman M, et al. High-throughput phe-
notyping using parallel sequencing of RNA interference targets in the African trypanosome. Genome
Res. 2011; 21(6):915–24. https://doi.org/10.1101/gr.115089.110 PMID: 21363968
3. Awuah-Mensah G, McDonald J, Steketee PC, Autheman D, Whipple S, D’Archivio S, et al. Reliable,
scalable functional genetics in bloodstream-form Trypanosoma congolense in vitro and in vivo. PLoS
Pathog. 2021; 17(1):e1009224. https://doi.org/10.1371/journal.ppat.1009224 PMID: 33481935
4. Barylyuk K, Koreny L, Ke H, Butterworth S, Crook OM, Lassadi I, et al. A Comprehensive Subcellular
Atlas of the Toxoplasma Proteome via hyperLOPIT Provides Spatial Context for Protein Functions. Cell
Host Microbe. 2020; 28(5):752–66.e9. https://doi.org/10.1016/j.chom.2020.09.011 PMID: 33053376
5. Carter M, Gomez S, Gritz S, Larson S, Silva-Herzog E, Kim HS, et al. A Trypanosoma brucei
ORFeome-Based Gain-of-Function Library Identifies Genes That Promote Survival during Melarsoprol
Treatment. mSphere. 2020; 5(5). https://doi.org/10.1128/mSphere.00769-20 PMID: 33028684
6. Eyford BA, Sakurai T, Smith D, Loveless B, Hertz-Fowler C, Donelson JE, et al. Differential protein
expression throughout the life cycle of Trypanosoma congolense, a major parasite of cattle in Africa.
Mol Biochem Parasitol. 2011; 177(2):116–25. https://doi.org/10.1016/j.molbiopara.2011.02.009 PMID:
21354217
7. Keroack CD, Elsworth B, Duraisingh MT. To kill a piroplasm: genetic technologies to advance drug dis-
covery and target identification in Babesia. Int J Parasitol. 2019; 49(2):153–63. https://doi.org/10.1016/j.
ijpara.2018.09.005 PMID: 30391230
8. Nyagwange J, Tijhaar E, Ternette N, Mobegi F, Tretina K, Silva JC, et al. Characterization of the Thei-
leria parva sporozoite proteome. Int J Parasitol. 2018; 48(3–4):265–73. https://doi.org/10.1016/j.ijpara.
2017.09.007 PMID: 29258832
9. Sidik SM, Huet D, Ganesan SM, Huynh MH, Wang T, Nasamu AS, et al. A Genome-wide CRISPR
Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Cell. 2016; 166(6):1423–35.e12.
https://doi.org/10.1016/j.cell.2016.08.019 PMID: 27594426
10. Dobbelaere D, Heussler V. Transformation of leukocytes by Theileria parva and T. annulata. Annu Rev
Microbiol. 1999; 53:1–42. https://doi.org/10.1146/annurev.micro.53.1.1 PMID: 10547684
11. McLeod A, Kristjanson R. Impact of ticks and associated diseases on cattle in Asia, Australia and Africa.
ILRI and eSYS report to ACIAR. International Livestock Research Institute, Nairobi, Kenya; 1999.
12. Terkawi MA, Thekisoe OM, Katsande C, Latif AA, Mans BJ, Matthee O, et al. Serological survey of
Babesia bovis and Babesia bigemina in cattle in South Africa. Vet Parasitol. 2011; 182(2–4):337–42.
https://doi.org/10.1016/j.vetpar.2011.05.047 PMID: 21700393
13. Bardosh K, Waiswa C, Welburn SC. Conflict of interest: use of pyrethroids and amidines against tsetse
and ticks in zoonotic sleeping sickness endemic areas of Uganda. Parasit Vectors. 2013; 6:204. https://
doi.org/10.1186/1756-3305-6-204 PMID: 23841963
14. Nene V, Morrison WI. Approaches to vaccination against Theileria parva and Theileria annulata. Para-
site Immunol. 2016; 38(12):724–34. https://doi.org/10.1111/pim.12388 PMID: 27647496
15. Autheman D, Crosnier C, Clare S, Goulding DA, Brandt C, Harcourt K, et al. An invariant Trypanosoma
vivax vaccine antigen induces protective immunity. Nature. 2021. https://doi.org/10.1038/s41586-021-
03597-x PMID: 34040257
16. Mosqueda J, Olvera-Ramirez A, Aguilar-Tipacamu G, Canto GJ. Current advances in detection and
treatment of babesiosis. Curr Med Chem. 2012; 19(10):1504–18. https://doi.org/10.2174/
092986712799828355 PMID: 22360483
17. Akama T, Zhang YK, Freund YR, Berry P, Lee J, Easom EE, et al. Identification of a 4-fluorobenzyl l-
valinate amide benzoxaborole (AN11736) as a potential development candidate for the treatment of
Animal African Trypanosomiasis (AAT). Bioorg Med Chem Lett. 2018; 28(1):6–10. https://doi.org/10.
1016/j.bmcl.2017.11.028 PMID: 29169674
PLOS PATHOGENS
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009955 October 14, 2021 6 / 7
18. Katris NJ, van Dooren GG, McMillan PJ, Hanssen E, Tilley L, Waller RF. The apical complex provides a
regulated gateway for secretion of invasion factors in Toxoplasma. PLoS Pathog. 2014; 10(4):
e1004074. https://doi.org/10.1371/journal.ppat.1004074 PMID: 24743791
19. Munday JC, Rojas Lopez KE, Eze AA, Delespaux V, Van Den Abbeele J, Rowan T, et al. Functional
expression of TcoAT1 reveals it to be a P1-type nucleoside transporter with no capacity for diminazene
uptake. Int J Parasitol Drugs Drug Resist. 2013; 3:69–76. https://doi.org/10.1016/j.ijpddr.2013.01.004
PMID: 24533295
20. Stewart ML, Burchmore RJ, Clucas C, Hertz-Fowler C, Brooks K, Tait A, et al. Multiple genetic mecha-
nisms lead to loss of functional TbAT1 expression in drug-resistant trypanosomes. Eukaryot Cell. 2010;
9(2):336–43. https://doi.org/10.1128/EC.00200-09 PMID: 19966032
PLOS PATHOGENS
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009955 October 14, 2021 7 / 7
